期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
布比卡因脂质体exparel应用研究进展 被引量:6
1
作者 邓梦秋 蒋鑫 袁红斌 《海军军医大学学报》 CAS CSCD 北大核心 2023年第8期965-970,共6页
布比卡因脂质体exparel是目前唯一上市的局部麻醉药缓释制剂,被批准用于成人单次局部浸润麻醉及肌间沟臂丛神经阻滞。随着区域阻滞技术的发展,exparel的超说明书应用逐渐增加。本文综述了近年来exparel在躯干神经阻滞、外周神经阻滞及... 布比卡因脂质体exparel是目前唯一上市的局部麻醉药缓释制剂,被批准用于成人单次局部浸润麻醉及肌间沟臂丛神经阻滞。随着区域阻滞技术的发展,exparel的超说明书应用逐渐增加。本文综述了近年来exparel在躯干神经阻滞、外周神经阻滞及椎管内麻醉中的应用,评价其安全性和有效性,并关注特殊人群应用的相关研究。 展开更多
关键词 exparel 布比卡因脂质体 神经阻滞 区域麻醉 手术后镇痛
下载PDF
Off Label Use of Exparel in an Axillary Block for Prolonged Postoperative Analgesia 被引量:1
2
作者 Reet Lawhon Robert LaCivita +1 位作者 John Fanouse Dennis Feierman 《Open Journal of Anesthesiology》 2015年第7期170-172,共3页
Post-operative analgesia is both necessary for patient comfort and satisfaction. Peripheral nerve block offer both good post-operative analgesia and patient satisfaction, but rarely cover the entire period of post-ope... Post-operative analgesia is both necessary for patient comfort and satisfaction. Peripheral nerve block offer both good post-operative analgesia and patient satisfaction, but rarely cover the entire period of post-operative pain. Nonnarcotic drugs are extremely helpful, but with severe pain, narcotics are usually used to help with post-operative pain when the nerve block wears off. However, nausea and vomiting, as well as other side effects associated with narcotic use can be severe and limit their use for post-operative analgesia. The addition of supplements to the local anesthetic used for the nerve blocks can extend the analgesia, but few blocks last greater than 24 hours. We describe the use of a relatively new extended release bupivacaine, Exparel that provide significantly longer analgesia than presently used single shot techniques protocols for extended nerve block analgesia. 展开更多
关键词 AMBULATORY NERVE BLOCK exparel
下载PDF
布比卡因脂质体EXPAREL 的发展及临床应用 被引量:6
3
作者 李和文 潘弘 甘莉 《中国处方药》 2021年第2期24-26,共3页
美国Pacira公司的布比卡因多囊脂质体Exparel于2011年获FDA批准上市至今已近十年,临床优势明显且取得了巨大市场成功,其与DepofoamTM技术平台成为目前国内外关注的研发及仿制热点。本文从该产品的处方、工艺、临床优势及市场情况四方面... 美国Pacira公司的布比卡因多囊脂质体Exparel于2011年获FDA批准上市至今已近十年,临床优势明显且取得了巨大市场成功,其与DepofoamTM技术平台成为目前国内外关注的研发及仿制热点。本文从该产品的处方、工艺、临床优势及市场情况四方面进行介绍分析,就Exparel的发展及临床应用做一简单综述。 展开更多
关键词 布比卡因 多囊脂质体 exparel 术后镇痛
下载PDF
Use of Liposomal Bupivacaine (Exparel) for Reduction in the Use of Postoperative Narcotics in an Obese Patient Undergoing Modified Radical Mastectomy
4
作者 Charles Keilin Evan P. Salant +3 位作者 Charusheela Andaz Reet Lawhon Piyush Gupta Dennis E. Feierman 《Open Journal of Anesthesiology》 2015年第6期113-115,共3页
Background: Obesity, particularly in the setting of comorbid disease, presents a unique challenge. Clinicians are pursuing areas of multimodal analgesia in an effort to minimize narcotic dosages. Post-operatively, the... Background: Obesity, particularly in the setting of comorbid disease, presents a unique challenge. Clinicians are pursuing areas of multimodal analgesia in an effort to minimize narcotic dosages. Post-operatively, their pain management can be even more challenging, which includes appropriate use of narcotics in a patient that has a high probably of sleep apnea. Aim: To show that the use of liposomal bupivacaine (Exparel) can provide effective post-operative pain relief and decrease the use of post-operative narcotics. Case: We report on a 62 years old female with a history of hypertension, obesity and a greater than a 40 pack year history of smoking who presented for a modified radical mastectomy with a lymph node dissection. At the end of the case, the patient’s wound was infiltrated with both free bupivacaine and Exparel that minimized her need for post-operative narcotics. Conclusion: We believe that the use of extended release local anesthetics should be considered when there is a need to reduce the use of post-operative narcotics. 展开更多
关键词 LIPOSOMAL BUPIVACAINE exparel NARCOTIC Sparing
下载PDF
布比卡因脂质体注射用悬浮液Exparel临床应用研究进展 被引量:8
5
作者 曾慧琳 施震 符旭东 《中国新药杂志》 CAS CSCD 北大核心 2014年第14期1654-1657,1650,共5页
长效酰胺类局麻药布比卡因常常用于术后镇痛,普通注射剂(浓度0.5%)产生不足7 h的镇痛作用,2011年美国食品药品监督管理局批准布比卡因脂质体注射用悬浮液Exparel上市,单剂量(浓度1.3%)直接注射产生长达72 h镇痛作用,这对于围手术期和术... 长效酰胺类局麻药布比卡因常常用于术后镇痛,普通注射剂(浓度0.5%)产生不足7 h的镇痛作用,2011年美国食品药品监督管理局批准布比卡因脂质体注射用悬浮液Exparel上市,单剂量(浓度1.3%)直接注射产生长达72 h镇痛作用,这对于围手术期和术后镇痛控制是很重要的。本文就近年来布比卡因脂质体注射用悬浮液Exparel临床应用的研究进展作一综述。 展开更多
关键词 布比卡因 多囊脂质体 术后镇痛 exparel
原文传递
EXPAREL~可减少阿片类药物的使用
6
作者 何俊劲 邢爱敏 《药学进展》 CAS 2012年第12期576-576,共1页
J PainRes(在线版)于2012年11月20日报道了布比卡因脂质体注射用混悬液(商品名:EXPAREL)的Ⅳ期临床研究数据。
关键词 exparel 布比卡因 脂质体 术后疼痛
原文传递
Evaluation of the Efficacy of Liposomal Bupivacaine Infiltrated into the Posterior Capsule for Postoperative Analgesia after Total Knee Arthroplasty—A Randomized Double Blind Clinical Trial 被引量:1
7
作者 Mohit Garg Piyush Gupta +2 位作者 Kevin Kang Avichai Dukshtein Dennis Feierman 《Open Journal of Anesthesiology》 2017年第11期381-392,共12页
Achieving adequate control of postsurgical pain remains a challenge in patients undergoing Total Knee Arthroplasty (TKA). The objective of this study was to assess if liposomal bupivacaine injected into the posterior ... Achieving adequate control of postsurgical pain remains a challenge in patients undergoing Total Knee Arthroplasty (TKA). The objective of this study was to assess if liposomal bupivacaine injected into the posterior capsule, in combination with a femoral nerve block and multimodal pain control regimen, would result in better pain control. The two groups were similar with regards to demographics and method of intraoperative anesthesia. Infiltration into the posterior capsule with liposomal bupivacaine had significantly lower resting pain scores compared to the saline group. Patients in the liposomal bupivacaine group also used slightly less breakthrough narcotic (5.75 to 4.31 mg of morphine equivalence). We recommend the use of infiltration of liposomal bupivacaine into the posterior capsule as an adjunct in multimodal analgesia in TKA patients to reduce pain and resultant narcotic use. 展开更多
关键词 LIPOSOMAL BUPIVACAINE exparel KNEE ARTHROPLASTY
下载PDF
A Case Series of 12 Patients Receiving Bilateral Transverse Abdominis Plane Blocks after Cesarean Section
8
作者 Dennis Feierman Aden Bronstein +4 位作者 Miriam Flaum Marc Dany Mohit Garg Piyush Gupta Kalpana Tyagaraj 《Open Journal of Anesthesiology》 2017年第12期407-414,共8页
Transverse abdominis Plane blocks (TAP) provide effective postoperative analgesia following surgical incisions of the lower and middle abdominal wall, including those associated with cesarean section. This study inves... Transverse abdominis Plane blocks (TAP) provide effective postoperative analgesia following surgical incisions of the lower and middle abdominal wall, including those associated with cesarean section. This study investigated the efficacy of liposomal bupivacaine diluted with 0.25% bupivacaine administered in bilateral TAP blocks for post-operative analgesia after Ce-sarean section preformed under neuraxial anesthesia. The patients who received the TAP blocks with liposomal bupivacaine had noticeably low pain scores of 1.0 ± 1.4, 1.4 ± 2.1, 1.7 ± 1.9, 1.9 ± 3.3 and 1.9 ± 2.3 at 6, 12, 24, 48 and 72 hours respectively. Only 3 patients used oxycodone (5 mg)/acetaminophen (325 mg) postoperative. One patient took two tables of oxycodone (5 mg)/acetamino-phen (325 mg) after 24 hours, a second patient used oxycodone (5 mg)/aceta-minophen (325 mg) after 72 hours and the third patient was transferred to the intensive care unit (ICU) since she developed postpartum cardiac complications, and was give oxycodone (5 mg)/acetaminophen (325 mg) despite having a 0 pain score. These results suggest that patients treated bilateral TAP blocks with a mixture of liposomal and regular bupivacaine will have low pain scores, high patient satisfaction and reduce the use of postoperative narcotics. 展开更多
关键词 LIPOSOMAL BUPIVACAINE exparel TAP Block Cesarean-Section
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部